22,607 Views
•
06:09 min
•
January 18, 2012
DOI:
The overall aim of this procedure is to assay the kinase activity of leucine rich repeat kinase two. This is accomplished by first preparing a kinase assay mixture with recombinant LA two and a myelin basic protein substrate. Next radio labeled a TP is added and the mixture is incubated for one hour.
Then the proteins are denatured, separated on a poly acrylamide gel and subjected to western blot. Finally, the membrane is exposed to a phospho screen and the activity is measured. Ultimately, results can be obtained that show that LA two is active and how mutations alter its activity through auto phosphorylation and phosphorylation of MBP.
Visual Demonstration of this method is critical as the radioactive steps are difficult to learn due to the safety precautions that need to be taken. Before beginning this procedure, refer to the written protocol regarding the proper use and disposal of radioactive isotopes to prevent the spread of radioactivity. Prepare all reaction mixtures in 1.5 milliliter sample tubes with screw caps containing an O-ring.
Begin the assay by first thawing wild type LA two protein as well as variants on ice. Then mix the following ingredients on ice. 10 nanomolar of kinase, 0.5 micrograms per milliliter, myelin basic protein 0.5 microliters of 10 times kinase buffer, and enough water to bring the volume up to 50 microliters.
After preparing the work area and or personnel for working with radioactivity, set heating blocks to 30 degrees Celsius and 100 degrees Celsius respectively. Remove 32 PATP from the minus 20 degrees Celsius freezer. Scan the outside of the container prior to use and th it behind a perspex screen.
Using the Geiger counter, assess the radioactivity of the 32 PATP to each reaction on ice. Add one microliter of 32 PATP and 10 micromolar of cold. A TP Use a per pet to mix well.
Then pulse centrifuge the reactions to bring the liquid to the bottom of the tube, thereby minimizing the risk of contamination. Next, remove a 15 microliter aliquot as a zero time point and terminate the reaction by adding five microliters of four times SDS sample buffer. Then denature the aliquot at 100 degrees Celsius for 10 minutes.
Incubate the remaining sample at 30 degrees Celsius for 60 minutes. Then remove a second 50 microliter aliquot. Add four times sample buffer and incubator 100 degrees Celsius for 10 minutes.
To resolve the reactions on SDS page, load 20 microliters of each sample onto a 10. Well, four to 12%Biss poly acrylamide gel along with a lane of protein standard. Run the gel with mops running buffer at 160 volts for 90 minutes or until the DIA front reaches the end of the gel.
Transfer the protein to PVDF membrane at 25 volts for 16 hours according to the steps outlined in the written protocol. Once the membrane has dried, place it between two cellulose acetate sheets and expose it to either a phosphorous screen or an x-ray film to detect radiolabeled protein exposure. Time can run from several hours to over a week depending on the specific activity of the radioisotope used and the enzyme kinetics of the reaction.
If using a phospho screen, save the image is a high resolution TIFF or bitmap file for film. Use a desktop scanner to first scan the film. Use image J for image analysis here.
Results for the assay carried out using wild type lark two as well as the G 2 0 1 9 S overactive kinase and D 1 99 4 A kinase dead variance with myelin basic protein as the phosphate scepter as shown auto phosphorylation of Lark two is visible at around 200 kilodaltons with multiple bands representing phosphorylated MBP visible from 20 to 40 kilodaltons. Note the absence of auto phosphorylation in the D 1 90 94 a lane and increased phosphorylation due to the G 2 0 1 9 s mutation. Residual phosphorylation of MVP in the kinase dead lane may be due to incomplete ablation of the kinase activity of Lark two by the D 1 99 4 A mutant or may reflect the presence of trace contaminating kinases in the reaction.
Don’t forget that working with radiation can be extremely hazardous and protective measures, such as shielding should always be used when undertaking a procedure such as this.
Leucine Rich Repeat Kinase 2 is a large multidomain kinase, mutations in which are the most common genetic cause of Parkinson's disease. Analysis of the kinase activity of this protein has proven to be a crucial tool in understanding the biology and dysfunction of this protein. In this paper, in vitro assaying of the kinase activity of LRRK2 and a selection of its mutants is described, providing an experimental system to examine phosphorylation of putative substrates and potential dysfunction of LRRK2 in disease.
08:05
Assaying Protein Kinase Activity with Radiolabeled ATP
Related Videos
18445 Views
08:55
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Related Videos
15155 Views
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Related Videos
6072 Views
12:49
Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Related Videos
7559 Views
11:11
Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Related Videos
7446 Views
11:23
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Related Videos
6253 Views
13:22
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Related Videos
7921 Views
N/A
Non-Radioactive In Vitro Cardiac Myosin Light Chain Kinase Assays
Related Videos
1873 Views
11:31
Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Related Videos
10065 Views
12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Related Videos
14920 Views
Read Article
Cite this Article
Lewis, P. A. Assaying the Kinase Activity of LRRK2 in vitro. J. Vis. Exp. (59), e3495, doi:10.3791/3495 (2012).
Copy